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ABSTRACT
Hepatitis B is a severe public health problem. The main world health centers have 
discussed it due to its pandemic proportion, high pathogenicity and infectivity. This study 
aimed to determine the immunization profile of dental surgeons - against hepatitis B virus 
(HBV) in the Public Health System (PHS) through the detection of anti-HBsAg antibodies by 
immunochromatography and associations with dental surgeons’ social and educational profile, 
factors related to professional knowledge and practices. This is a cross-sectional study on 
the prevalence of vaccination and immune status to HBV in dentists of Sao Paulo State PHS. 
Data collection occurred in three stages: questionnaire application, analysis of adhesion to the 
vaccination protocol and anti-HBsAg tests. Statistical analysis used the Bivariate Analysis and 
the Binary Logistic Regression. From the total of 219 interviewees, 74.9% reported having 
received three doses of the vaccine, but 35.6% were not immune to HBV. The dependent 
variable was associated with years in the public service (years) (OR [Odds Ratio]=1.04; 
95% CI 1.00-1.08); knowledge on the subject (OR=6.93; 95% CI 1.39-34.40); incorrect 
answer concerning the etiological agent of the disease (OR=2.60; 95% CI 1.30-5.22); 
ignorance on the number of vaccine doses that have been administered (OR=3.43; 
95% CI 1.14-10.30); and less than three doses of the vaccine in the immunization schedule 
(OR=8.76; 95% CI 3.50-21.91). A considerable portion of professionals non-immune to the 
HBV were found. We concluded that knowledge, years of practice and completion of the 
vaccination schedule (three doses) affected dental surgeons’ immune status to HBV. 
KEYWORDS: Hepatitis B. HBV. Anti-HBsAg. Australian antigen. Vaccination. 
Immunization. Dentistry.
INTRODUCTION
Hepatitis B consists of a severe infection in the liver. It is a pandemic disease with 
significant epidemiological indices. Estimates have suggested that about 2 billion 
people are infected with hepatitis B virus (HBV), and approximately 325 million 
live with chronic liver disease without access to diagnostic tests and treatments1,2. 
Among viral hepatitis, the B and C types account for 96% of deaths and morbidity 
rates due to cirrhosis and liver cancer in the world2. For that reason, the World 
Health Organization (WHO) has published guidelines and recommendations to 
warn health services and professionals about the risks of infection, the importance 
of prevention and the need of implementing public health policies related to this 
disease1. Likewise, a manual published in 2017 on tests to diagnose hepatitis B and 
C aimed at encouraging, expanding and strengthening health coordinated actions to 
make these laboratory tests available to the main vulnerable groups3.
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The great discussion about hepatitis B in the main world 
health centers is related to the high HBV infectivity and anti-
viral resistance which is up to 100 times higher than that of 
the human immunodeficiency virus (HIV)4 and 10 times 
higher than that of the hepatitis C virus (HCV)5,6. This 
characteristic is related to the social conjecture, particularly 
in developing countries, since this disease is mainly silent and 
asymptomatic. Furthermore, it can evolve through different 
paths depending on the age, lifestyle and the patient’s 
general health condition, aside from HBV genotypes and 
subgenotypes and mode of the pathogen’s acquisition7,8. 
The vulnerable groups to this disease include health 
care professionals, who have a higher prevalence of HBV 
infections than the general population, regardless of 
the endemic condition in the region where they live9,10. 
Therefore, approaching this subject in relation to dental 
professionals is essential, since they perform unsanitary 
activities in continuous and direct contact with the main 
modes of HBV transmission: blood and saliva11,12. Besides, 
associated factors make dental surgeons more susceptible 
to this disease: high rates of laboratory accidents with 
contaminated sharp equipment, poor biosafety practices, 
negligent self-care, high virus pathogenicity and lack of 
immunization against HBV13,14.
The vaccine against HBV was developed in the 
1970s. Since 1986, it has been widely distributed and has 
demonstrated to be highly reliable, accurate and safe, so that 
it is considered the main preventive method against hepatitis 
B. For this reason, this preventive measure (vaccination) is 
not only a self-care practice of dental surgeons, but also the 
most efficient measure to protect patients’ health, reducing 
the incidence of the disease15. 
Even though the vaccine is highly immunogenic, 
around 10% of individuals who have completed their 
immunization schedule with three doses (0, 30 and 
180 days) do not develop protective immunity, i.e., their 
antibody titers against HBV surface’s antigen (anti-HBs) 
are lower than 10 mIU/mL. The main procedure to ascertain 
immunization is by performing a post-vaccination anti-HBs 
seroconversion test (6 to 8 weeks after the last dose) using 
enzyme immune assays and immunochromatography. 
The seroconversion status is an essential information for 
health professionals, as a booster dose may be necessary 
to stimulate the production of higher antibody levels16,17.
Thus, considering that the Brazilian public health is 
one of the main sectors concentrating the labor force of 
dental surgeons in the country and that few researches have 
determined the vaccine protection status and prevalence in 
this risk group through a reliable, recommended, laboratory-
based methodology, accessible to the population, this study 
aimed to determine in the dental surgeons working in the 
Public Health System (PHS), their immune profile against 
HBV by means of anti-HBsAg enzyme immunoassays and 
immunochromatography, and its association with the social 
and educational profile of dental surgeons, as well as with 
factors related to professional knowledge and practices. 
MATERIALS AND METHODS
Study design 
This is a cross-sectional epidemiological study. Its 
population comprises all of the dental surgeons in the PHS, 
in all the 40 municipalities (a total of 774,441 inhabitants) 
in the Northwest region of Sao Paulo State covered by the 
Regional Health Department II (DRS II).
Sao Paulo State is located in the Southeast region of 
Brazil and has the highest number of dental surgeons in 
the country. Administratively, Sao Paulo is divided into 
17 Regional Health Departments18 to meet the Brazilian 
Unified Health System’s (SUS) guidelines and to comply 
with the institutional reforms agreed by the federated 
entities (the Union, States and municipalities) in the 2006 
Covenant for Health Care (Pacto pela Saude) (Ordinance 
Nº 3999/2006)19. 
According to the information provided by the DRS II 
at the time of data collection, there were 276 active dental 
surgeons in the Public Health System. All the professionals 
who accepted participating in the study signed the Informed 
Consent. The exclusion criteria comprised municipal 
managers who did not authorize to carry out the study in 
their cities and dental surgeons who were laid off or were on 
work leave or maternal leave, retired, retirees of those who 
were absent after two visits during the data collection period. 
Data collection
We divided the data collection into three stages as 
follows. 
1st Stage
The first stage consisted of the application of a 
self-administered, semi-structured questionnaire. This 
instrument has been developed for this research. In order 
to design it, we conducted a wide bibliographic survey 
to include valid, sensitive and inferential variables. We 
divided the instrument into three dimensions: the first 
one has covered issues related to social, educational and 
demographic characteristics of the interviewees; the 
second dimension has investigated the representativeness 
of the professionals’ knowledge and mastery regarding 
the hepatotropic virus type B, the transmissibility of viral 
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pathogens and the immunogenicity of the vaccine against 
HBV; and the third dimension determined the participants’ 
valuation of their self-care practices.
We carried out a pilot study to investigate the 
instrument’s applicability and operability to meet the study 
goal. The application of the instrument occurred in the 
participants’ workplace, without disturbing or interfering 
with the clinic organization and the scheduled appointments. 
2nd Stage
After the first stage, participants were individually 
forwarded to a private room provided by each health 
institution. At this moment, we requested the participants’ 
immunization record and verified the completeness of the 
immunization protocol against HBV (three doses of the 
vaccine). In addition, we questioned the participants about 
the previous anti-HBs seroconversion test and its result. 
3rd Stage
The last study stage verified the participants’ 
immunization status through a rapid anti-HBsAg® 
immunochromatographic assay (Wama Diagnostica, Sao 
Carlos, SP, Brazil). The data collection procedures followed 
all biosafety rules and recommendations to protect the 
physical integrity of the participants and guarantee the tests 
reliability and sensitivity. 
The rapid test is based on the immunochromatographic 
technology; it uses the sandwich principle to detect anti-
HBsAg antibodies in human serum, plasma, or whole 
blood. Firstly, blood was collected through a fingerstick 
procedure with a sterile, disposable lancet. Then, blood 
from the fingertip was collected with a capillary tube. An 
approximate blood volume of 100 μL was immediately 
placed in the sample well indicated by the device. The 
result was read 15-20 min after the beginning of the assay.
The device employed is based on an immuno-
chromatographic method. A positive result (the individual is 
considered immunized), occurs when the antibodies against 
the HBV surface antigen (anti-HBs) present in the sample 
bind to the HBsAg-colloidal gold conjugate, forming 
antigen-antibody complexes. This ensemble moves to the 
test area (T), where it binds to HBsAg antigens and shows 
a reddish pink band. Next, the remaining ensemble flows 
to the control area (C) and binds to anti-HBsAg antibodies 
in the control area, showing a second reddish pink band in 
this region, therefore determining the immunized status. 
Negative results indicate that the individual was not 
immunized at all or that there is an insufficient level 
of antibodies, determining the non-immune status of 
individuals (<10 mIU/mL). This confirmation occurs when 
there is only one reddish pink band in the control area (C), 
while the test area does not show any reaction (pink band). 
Data analysis
We performed data tabulation and statistical analysis 
using the Statistical Package for the Social Sciences 
(SPSS for Windows, version 22.0, IBM, Armonk, New 
York, USA), and carried out the bivariate analysis using 
the Pearson’s chi-square test, Fisher’s exact test or the 
maximum likelihood ratio test, with a p-value <0.050 to 
verify associations between dependent and independent 
variables. Concerning the quantitative variables analyses 
(age, years after graduation, years in the public service), we 
initially applied the Kolmogorov-Smirnov test for normality 
(p≤0.05). However, as this test did not meet our purpose, we 
used the Mann-Whitney non-parametric test, considering a 
significance level of 5% (p≤0.05). 
Next, we conducted a binomial logistic regression 
analysis with gross and adjusted estimates of odds ratios 
(OR) in order to control confounding variables and to 
identify factors modifying the mentioned event. This model 
included all the associations found between the dependent 
variable and the corresponding independent variables, 
considering a p-value <0.001. The confidence interval was 
adjusted to 95% and results were displayed as ORs.
Ethical and legal aspects
This research was approved by the Ethics and Research 
Committee (Protocol Nº CAAE 54227416.0.0000.5420) 
and it complied with all ethical principles for research with 
human beings according to Resolution Nº 466/2012 of the 
Brazilian National Health Council. 
RESULTS
From a total population of 276 dental surgeons, four 
were on work or maternal leave, 24 did not want to 
participate in the study and 16 were not present after two 
interview attempts. In addition, 13 professionals did not 
participate in the study because three managers did not 
authorize the study in their cities. Therefore, the sample 
comprised 219 (79.4%) dental surgeons from 37 cities. 
We identified that 95.9% of participants reported to be 
immunized against HBV and 74.9% received at least 
three doses of the vaccine. However, the anti-HBsAg 
seroconversion test indicated that 35.6% of dental 
surgeons were not immunized against HBV. 
Table 1 shows the dental surgeons’ social and 
educational profile. Most participants were female (65.8%), 
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Table 1 - Bivariate analysis of social and educational factors with respect to the dependent variable (immunization to hepatitis B). 
Sao Paulo, Brazil, 2019.
Social and educational factors
What is the result of the immunization 
test? Total p-valueNon immunized Immunized
n % n % n %
Sex 0.062
Male 33 42.3 42 29.8 75 34.2
Female 45 57.7 99 70.2 144 65.8
Marital status 0.298
Not married 28 35.9 41 29.1 69 31.5
Married/Common-law marriage 50 64.1 100 70.9 150 68.5
Age group (years) 0.493**
20 to 29 9 11.5 16 11.3 25 11.4
30 to 39 12 15.4 34 24.1 46 21.0
40 to 49 31 39.7 48 34.0 79 36.1
50 to 59 20 25.6 37 26.2 57 26.0
60 or older 6 7.7 6 4.3 12 5.5
Ethnicity 0.262**
White 60 76.9 116 82.9 176 80.4
Mixed (black and white) 6 7.7 4 2.9 10  5.0
Asian 12 15.4 20 14.3 32 14.6
Years after graduation 0.189
< 5 7 9.0 12 8.5 19 8.7
5 to 10 6 7.7 17 12.1 23 10.5
11 to 20 13 16.7 38 27.0 51 23.3
21 to 30 39 50.0 49 34.8 88 40.2
>30 13 16.7 25 17.7 38 17.4
Years in the public healthcare service 0.172**
<5 7 9.0 27 19.1 34 15.5
5 to 10 11 14.1 26 18.4 37 16.9
11 to 20 27 34.6 42 29.8 69 31.5
21 to 30 32 41.0 43 30.5 75 34.2
>30 1 1.3 3 2.1 4 1.8
Workload 0.106
Up to 20 HPW*** 54 69.2 82 58.2 136 62.1
>20 HPW 24 30.8 59 41.8 83 37.9
Schooling 0.575**
Undergraduate Course 40 51.3 60 42.6 100 45.7
Specialist Degree 35 44.9 72 51.1 107 48.9
Master’s Degree 2 2.6 7 5.0 9 4.1
PhD 1 1.3 2 1.4 3 1.4
Smoker 1.000*
No 73 93.6 133 94.3 206 94.1
Yes 5 6.4 8 5.7 13 5.9
Use of alcoholic beverages 0.014
No 28 35.9 75 53.2 103 47.0
Yes 50 64.1 66 46.8 116 53.0
Sexual orientation 0.289*
Heterosexual 76 97.4 140 99.3 216 98.6
Homosexual 2 2.6 1 0.7 3 1.4
Relative who had or has hepatitis B 0.776*
No 74 94.9 132 93.6 206 94.1
Yes 4 5.1 9 6.4 13 5.9
Total 78 100.0 141 100.0 -
*Fisher’s exact test; **Maximum likelihood ratio; *** HPW – hours per week.
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married (68.5%), have graduated from 21 to 30 years ago 
(34.2%), have worked for 1 to 20 years in the public service 
and held a specialist degree (48.9%). We found a statistically 
significant association between the use of alcoholic 
beverages and the participants’ immunization (Table 1). 
Table 2 shows that most professionals reported 
having received guidance on hepatitis B (94.5%), and 
this information was provided during their undergraduate 
program (48.3%). However, the average years after 
graduation is 20.93 (SD±10.08), and 92.7% have not 
attended any course in the past two years. Half (50.2%) of 
interviewees were wrong in answering what is the etiological 
agent of hepatitis B, 72.1% confused or gave an incomplete 
answer on the modes of transmission of the disease, and 
only 19.2% correctly answered the preventive measures 
against the disease in the dental clinic. The dependent 
variable showed statistically significant associations with 
“He/She received guidance on hepatitis B” (p=0.009) and 
“He/She knows the etiologic agent” (p=0.000) (Table 2).
Table 3 shows the dental surgeons’ self-care practices 
with 95.9% having stated that they had been vaccinated 
against HBV; however, 23.8% of participants did not know 
how many doses they had received or they had received 
less than three doses. This situation occurred because some 
participants did not bring their immunization card to the 
interview, as previously requested. Only 80 (36.5%) dental 
surgeons had performed the anti-HBs assay previously, 
and 32.8% of them had a negative immunization result. 
Another result had great representativeness in almost half 
of the participants (48.4%) who reported having already 
Table 2 - Bivariate analysis of knowledge factors and the dependent variable (immunization to hepatitis B), Sao Paulo, Brazil, 2019.
Knowledge factors
What is the result of the 
immunization test? Total p-valueNon immunized Immunized
n % n % n %
Received guidance on hepatitis B 0.009*
No 9 11.5 3 2.1 12 5.5
Yes 69 88.5 138 97.9 207 94.5
If yes, where? 0.003
Undergraduation 30 43.5 70 51.5 100 48.3
Graduation 3 4.3 25 18.4 28 13.5
Public Service 12 17.4 18 13.2 30 14.5
Media 24 34.8 23 16.9 47 22.7
Attended any course in the past two years 0.480
No 71 91.0 132 93.6 203 92.7
Yes 7 9.0 9 6.4 16 7.3
Knowledge the etiologic agent 0.000
Incorrect answer 52 66.7 58 41.4 110 50.2
Correct answer 26 33.3 82 58.6 108 49.3
What is the risk of contracting hepatitis B? 0.894**
High 59 78.7 107 75.9 166 75.8
Medium 13 17.3 28 19.9 41 18.7
Low 3 4.0 6 4.3 9 4.1
Modes of transmission of hepatitis B 0.855
Incorrect answer 9 11.5 13 9.2 22 10.0
Correct answer 21 26.9 40 28.4 61 27.9
Incomplete answer 48 61.5 88 62.4 136 62.1
The main preventive measure against hepatitis B in the 
dental clinic 0.885
Incorrect answer 10 12.8 20 14.2 30 13.7
Correct answer 14 17.9 28 19.9 42 19.2
Incomplete answer 54 69.2 93 66.0 147 67.1
Does the vaccination against hepatitis B last a lifetime? 0.683
No 39 56.5 69 53.5 108 49.3
Yes 30 43.5 60 46.5 90 41.1
Total 78 100.0 141 100.0 -
*Fisher’s exact test; **Maximum likelihood ratio
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had a history of accident with sharp instruments, with 
recurrence in 62.2% of the cases, mainly when recapping 
needles (66%). Even though 76% of participants were aware 
of the protocol for accidental puncture wounds, less than 
half (53%) sought medical care or performed any exams 
(Table 3). 
Concerning the bivariate analyses, the immunization 
profiles of participants had statistically significant 
associations with the variable “How many doses of 
the vaccine against hepatitis B have you received?” 
(p=0.000) and “Do you wash your hands after each clinical 
appointment?” (p=0.036). Furthermore, the Mann-Whitney 
test found associations with the number of years in the 
public service (p=0.038).
The multivariate analysis (Table 4) carried out through 
the binomial logistic regression indicated that the number 
Table 3 - Bivariate analysis of factors related to professional practices and the dependent variable (immunization to HBV) –Brazil, 2019.
Factors related to professional practices
What is the result of the immunization 
test? Total p-valueNon immunized Immunized
n % n % n %
Received the vaccine 0.072*
No 6 7.7 3 2.1 9 4.1
Yes 72 92.3 138 97.9 210 95.9
How many doses of the vaccine against hepatitis B did 
you receive? 0.000
Do not know/ Do not remember 14 18.2 7 5.0 21 9.6
Less than three doses 21 27.3 10 7.2 31 14.2
Three doses or more 42 54.5 122 87.8 164 74.9
Have you ever performed the anti-HBs test? 0.375
No 52 66.7 83 60.6 135 61.6
Yes 26 33.3 54 39.4 80 36.5
If yes, what was the result? 0.053
Negative 13 54.2 14 30.4 27 27
Positive 11 45.8 32 69.6 43 43
Do you wash your hands after each clinical appointment? 0.036
Always 58 74.4 121 85.8 179 81.7
Sometimes 20 25.6 20 14.2 40 18.3
Use of personal protective equipment 0.681
Always 69 88.5 122 86.5 191 87.2
Sometimes 9 11.5 19 13.5 28 12.8
Adherence to the biosafety protocol 0.627
Always 68 87.2 126 89.4 194 88.6
Sometimes 10 12.8 15 10.6 25 11.4
Have you ever had an accident with sharp instruments? 0.725
No 39 50.0 74 52.5 113 51.6
Yes 39 50.0 67 47.5 106 48.4
If yes, how many times? 0.599**
Once 18 46.2 22 32.8 40 37.7
Twice 13 33.3 27 40.3 40 37.7
Three times 5 12.8 11 16.4 16 15.1
Four times 3 7.7 7 10.4 10 9.4
If yes, which instruments? 0.748
Needle (recapping) 25 64.1 45 67.2 70 66.0
Other 14 35.9 22 32.8 36 34.0
If yes, did you follow the protocol? 0.171
No 15 38.5 35 52.2 50 47.2
Yes 24 61.5 32 47.8 56 52.8
Total 78 100.0 141 100.0 -
*Fisher’s exact test; **Maximum likelihood ratio
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of years of practice is a risk factor, as each additional year 
increased the risk of non-immunization was OR=1.041; 
95% CI 1.00-1.08. Likewise, participants who did not 
receive any guidance on hepatitis B and those who confused 
the etiologic agent had OR=6.935; 95% CI 1.39-34.40 and 
OR=2.609; 95% CI 1.30-5.22. i.e. had more chances not 
to be immunized, respectively. Participants who did not 
know/did not remember how many vaccine doses they 
had received showed OR=3.437; 95% CI 1.14-10.30, 
having more chances not to be immunized, while those 
who had received less than three doses had OR=8.760; 
95% CI 3.50-21.91 of non-immunization compared to those 
who had three or more doses (Table 4).
DISCUSSION
This is one of the first studies carried out with dental 
surgeons in the PHS, in Brazil, aiming at mapping 
the immunization of these professionals using the 
immunochromatographic technology to identify the level 
of anti-AgHBs antibodies in this specific population.
This investigation found that 35.6% of dental surgeons 
in the PHC were not immunized against HBV, pointing out 
a contrast between professional vulnerability and self-care 
negligence. 
In Brazil, after more than 30 years since the vaccine 
against hepatitis B was introduced in the national 
immunization program in the PHS, the adhesion of dental 
academics and dental surgeons is still inconsistent and 
negligent, as shown by the anti-HBs seroconversion 
assay17. Although health institutions recommend and 
guide immunization, some professionals do not follow the 
regulations, causing a failure in their self-care. In addition, 
the lack of efficient mechanisms for inspection and control 
of these health actions contributes to this negligent and 
reckless behavior.
By analyzing studies performed with dental professionals 
in other countries, we observed a different situation in 
comparison with the one identified in this study. In Iran, 
11.5%20 of professionals were not immunized against 
HBV; in Spain, the estimate was 27.02%21; in Italy, 17%22; 
in the Netherlands, 12%23; and in the USA, only 7.1%24. 
What may justify this high prevalence of non-vaccination 
or non-protection among Brazilian dental surgeons is the 
possibility of a gradual decline of antibody levels, from 13 to 
60%, one year after the end of the immunization schedule21. 
Table 4 - Gross and adjusted multivariate analysis of the associations between the dependent variable and factors related to social 
and educational aspects, knowledge and professional practices, Sao Paulo, Brazil, 2019.
Variables
Logistic regression
ORCrude (95% CI) p-value ORAdjusted (95% CI) p-value
Years in the public healthcare service 1.033 (1.001-1.065) 0.044 1.041 (1.001-1.081) 0.043
Sex
Male 1.729 (0.971-3.076) 0.063 1.580 (0.782-3.193) 0.202
Female - - - -
Use of alcoholic beverages
No - - - -
Yes 2.029 (1.149-3.584) 0.015 1.741 (0.875-3.466) 0.114
Received guidance on hepatitis B
No 6.000 (1.574-22.873) 0.009 6.935 (1.398-34.408) 0.018
Yes - - - -
Knowledge on the etiologic agent
Incorrect answer 2.828 (1.585-5.043) 0.000 2.609 (1.303-5.226) 0.007
Correct answer - - - -
How many doses of the vaccine against 
hepatitis B did you receive? 
Do not know/Do not remember 5.810 (2.196-15.366) 0.000 3.437 (1.147-10.300) 0.028
Less than three doses 6.100 (2.658-13.999) 0.000 8.760 (3.502-21.913) 0.000
Three doses or more - - - -
Do you wash your hands after each clinical 
appointment?
Always - - - -
Sometimes 2.086 (1.042-4.177) 0.038 1.292 (0.558-2.993) 0.550
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Other factors associated to anti-HBs seroconversion 
can affect the production of antibodies, reducing the 
effectiveness of vaccinated individuals’ immunization, such 
as vaccine storage methods, correct administration of doses, 
the immunization program and the protocol followed by 
each healthcare service25. In addition, we verified through 
a systematic review and meta-analysis that male, adult, 
elderly individuals with BMI (Body Mass Index) ≥ 25, who 
smoke and have concomitant comorbidities, have higher 
risks of immunization failure, reinforcing the importance of 
performing the anti-HBs evaluation, and providing booster 
doses of the vaccine against HBV26.
Another expressively relevant issue in this study was the 
association between the number of vaccine doses and the 
non-immunization of dental surgeons. This association was 
due to the non-completion of the immunization schedule 
by the study participants (they did not remember or they 
received less than three doses), justifying the deficient 
immune protection20,27.
Nowadays, thanks to the evolution of genetic engineering, 
the immunization schedule comprises three doses, which 
must respect the administration interval between them (0, 
30, 180 days), so that the immunization against the virus is 
guaranteed, with anti-HBs titers higher than 10 mIU/mL2. 
Concerning the vaccine coverage, a study conducted with 
participants in Australia, Belgium, Canada, Czech Republic, 
Germany, New Zealand, the Philippines, Russia, Spain, and 
the United States determined that the protective response 
occurs in 95% of children and adolescents, 90% of health 
young adults up to 49 years old, and ≥80% of individuals 
aged 60 years old or over28. In addition, according to WHO, 
immunosuppressed and hemodialised individuals have 
50-70% of immunization against HBV, and individuals 
with liver disease have 60-70%29.
However, the knowledge and confirmation on the 
immunization status through the anti-HBs test is not 
recommended to the whole population because of the 
vaccine effectiveness. Nevertheless, health professionals, 
due to their vulnerability and exposure to occupational 
unhealthy procedures, are supposed to confirm their 
protection and be concerned with the maintenance of this 
status20,30,31. For the same reason, individuals with low 
antibody levels and complete immunization schedule need 
to receive a booster dose, because, despite the premise 
of immunological memory, this supplementary dose is 
recommended to this vulnerable group, given their exposure 
to the main modes Hepatitis B transmission2.
Regarding the knowledge of dental surgeons about the 
subject approached, we found gaps concerning elementary 
issues of hepatitis B, modes of transmission, and disease 
prevention in the dental clinic context. The statistical 
analysis pointed out the influence of this dimension on the 
representativeness of non-immunized individuals.
This association confirms the relevance of professional 
training, since acquiring this knowledge reflects in the 
practices and self-care conducts of dental professionals. 
Costa et al.32 observed that primary health care workers 
who have more knowledge on occupational health are 
more favorable to vaccination. Other studies observed this 
same behavior in Brazilian and Lithuanian dental surgeons, 
especially in the younger ones33,34. Garbin et al.35 analyzed 
the knowledge of PHC dental surgeons and concluded that 
the representativeness of hepatitis B in the professionals’ 
concept does not match its actual pathogenic and 
epidemiological significance, requiring more professional 
preparation measures to face diseases in public health and 
disrupt critical nodes.
Regarding professional practices, even without the 
confirmation of statistically significant associations, we 
found a high percentage of participants with a recurrent 
history of accidents with sharp equipments, mainly when 
recapping needles. Other studies have also observed this 
occurrence11,32, and they suggested the need for a continuous 
training of dental professionals and thematic debates in the 
workplace to provide dental surgeons with knowledge and 
showing them the value of self-care measures.
A decrease in diseases caused by work activities in 
healthcare settings happened after recognizing the biosafety 
axiom in the medical practice, the use of personal protective 
equipment, and the creation of protocols on pre- and post-
exposure to contaminated materials and fluids36. However, 
even with minimized occupational risks, accidents are 
still significantly frequent. Their potential of developing 
diseases in non-immunized individuals must be considered, 
particularly regarding HBV, since its infectivity ranges from 
6 to 30% in accidents with sharp materials and blood known 
to be contaminated. A tiny amount of contaminated blood 
(0.0001 mL) is enough to transmit the pathogen37. 
The laboratory method used in this study was the 
immunochromatographic technology-based rapid assay 
due to its suitability for the investigation and screening 
at the population level, in endemic areas or in vulnerable 
groups. This method’s advantages are the low cost, high 
specificity, rapid test processing, easy technical features, 
diagnosis efficiency, high patient’s acceptance, and no need 
for a laboratory infrastructure38-40. Further, we chose this 
technology based on the WHO’s guidelines to track the 
HBV antigen and antibody levels and to eliminate hepatitis 
B as one of the main threats to public health3.
Due to the cross-sectional, epidemiological nature of 
this study, its limitations included the use of a questionnaire 
assessing memory-based variables, so the answers given 
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in the questionnaire application have a potential for bias. 
The study results indicated the presence of individuals 
immunized against HBV who stated they were not 
vaccinated (n = 3) and had less than three doses of the 
vaccine (n = 10). This contradiction can be explained by the 
fact that these participants did not show their immunization 
record during data collection and, due to the memory-
based variables, these data can be biased. In addition, we 
used the rapid immunochromatographic assay to analyze 
the immunization of participants against HBV, which has 
a lower specificity and sensitivity rate when compared to 
other laboratory methods. However, this technique has 
several advantages and is used in population studies. 
CONCLUSION
We found a considerable number of dental surgeons in 
the Public Health System non-immunized against HBV. 
They are vulnerable and exposed to the main modes of 
virus transmission, especially due to the high prevalence of 
occupational accidents. Furthermore, knowledge, years in 
the public service and the value given to self-care related to 
the immunization schedule completion affected the vaccine 
protection. 
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